Generics in France
SummaryGenerics in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
- The French generics market recorded revenues of $4.5 billion in 2023, representing a compound annual growth rate (CAGR) of 5.5% between 2018 and 2023.
- Market consumption volume increased with a CAGR of 1.5% between 2018 and 2023, to reach a total of 37.6% of total pharma volume in 2023.
- According to GlobalData, in 2023, the French generics market grew by 5.7% annually. The growth is attributed to the country’s mounting aging population. According to the United States Census Bureau, in 2023, the population aged 65 years and above in France reached 14.7 million, up 2.7% over 2022.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in France
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in France
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the France generics market with five year forecasts by both value and volume
Reasons To Buy
- What was the size of the France generics market by value in 2023?
- What will be the size of the France generics market in 2028?
- What factors are affecting the strength of competition in the France generics market?
- How has the market performed over the last five years?
- Who are the top competitors in France's generics market?
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.